COVID-19 immunization threshold(s): an analysis
Bautista Balbas, L. A.; Gil Conesa, M.; Bautista Balbas, B.; Alcaide Jimenez, A.; Rodriguez Caravaca, G.
Show abstract
2As COVID-19 vaccine research efforts seem to be yielding the first tangible results, the proportion of individuals needed to reap the benefits of herd immunity is a key element from a Public Health programs perspective. This magnitude, termed the critical immunization threshold (q), can be obtained from the classical SIR model equilibrium equation, equaling (1 - 1/R0)/ {epsilon}, where R0 is the basic reproduction number and{epsilon} is the vaccine efficacy. When a significant proportion of the population is already immune, this becomes (n - 1/R0)/ {epsilon}, where n is the proportion of non-immune individuals. A similar equation can be obtained for short-term immunization thresholds(qt), which are dependent on Rt. qs for most countries are between 60-75% of the population. Current qt for most countries are between 20-40%. Therefore, the combination of gradual vaccination and other non-pharmaceutical interventions will mark the transition to the herd immunity, providing that the later turns out to be a feasible objective. Nevertheless, immunization through vaccination is a complex issue and many challenges might appear.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Immunity acquired by a minority active fraction of the population could explain COVID-19 spread in Greater Buenos Aires (June-November 2020) 92%
- Preceding anti-spike IgG levels predicted risk and severity of COVID-19 during the Omicron-dominant wave in Santa Fe city, Argentina 92%
- Analysis of the early Covid-19 epidemic curve in Germany by regression models with change points 91%
Similar papers in this journal
- Modelling optimal vaccination strategies against Covid-19 in a context of Gamma variant predominance in Brazil 95%
- Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia 94%
- COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery 94%
Similar papers in this journal
- Modeling the impact of COVID-19 vaccination in Lebanon: A call to speed-up vaccine roll out 94%
- Analysis of host immunological response of adenovirus-based COVID-19 vaccines 93%
- Cost-effectiveness of quadrivalent versus trivalent inactivated influenza vaccines for the Portuguese elderly population 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.